Cardiac Surgery
Conditions
Keywords
continuous glucose monitoring
Brief summary
The goal of this clinical trial is to evaluate accuracy of continuous glucose monitoring device called 'Dexcom G7' in patients undergoing cardiac surgery.
Interventions
DEVICEDexcom G7
Continuous glucose monitoring device (Dexcom G7) will be applied to patients undergoing cardiac surgery intraoperatively and postoperatively (maximum 10 days)
Sponsors
Seoul National University Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients aged 19 years or older scheduled for cardiac surgery
Exclusion criteria
* Skin disease at the sensor application site (proximal arm)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| MARD | From the beginning of operation to the end of postoperative ICU stay (maximum 10 days) | mean absolute relative difference |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Bland-Altman analysis | From the beginning of operation to the end of postoperative ICU stay (maximum 10 days) | mean difference, bias, 95% limits of agreement |
| ISO criteria | From the beginning of operation to the end of postoperative ICU stay (maximum 10 days) | Satisfaction of 2013 ISO (International Organization of Standardization) criteria |
| DTS error grid | From the beginning of operation to the end of postoperative ICU stay (maximum 10 days) | DTS (Diabtetes Technology Society) error grid |
Countries
South Korea
Contacts
CONTACTKaram Nam, M.D., Ph.D.
Outcome results
None listed